Nicolás André

15.8k total citations · 1 hit paper
264 papers, 8.6k citations indexed

About

Nicolás André is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nicolás André has authored 264 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 90 papers in Oncology and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nicolás André's work include Glioma Diagnosis and Treatment (41 papers), Neuroblastoma Research and Treatments (36 papers) and Childhood Cancer Survivors' Quality of Life (29 papers). Nicolás André is often cited by papers focused on Glioma Diagnosis and Treatment (41 papers), Neuroblastoma Research and Treatments (36 papers) and Childhood Cancer Survivors' Quality of Life (29 papers). Nicolás André collaborates with scholars based in France, United States and Australia. Nicolás André's co-authors include Eddy Pasquier, Maria Kavallaris, Manon Carré, Diane Braguer, Joseph Ciccolini, Laëtitia Padovani, Xavier Sastre‐Garau, Claudette Briand, Dominique Barbolosi and Didier Meseure and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Nicolás André

258 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

2022 173 citations Eleonora Timperi, Paul Gueguen et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolás André France	50	4.1k	2.8k	1.8k	1.2k	882	264	8.6k
Amit Maity United States	45	3.4k 0.8×	2.7k 1.0×	1.9k 1.0×	1.2k 1.0×	1.0k 1.2×	153	7.2k
Joel M. Reid United States	51	4.5k 1.1×	3.0k 1.1×	958 0.5×	1.6k 1.4×	656 0.7×	270	10.0k
Mark A. Watson United States	48	3.4k 0.8×	1.9k 0.7×	1.7k 0.9×	1.4k 1.2×	457 0.5×	129	7.2k
Pamela N. Münster United States	58	6.1k 1.5×	4.6k 1.7×	1.2k 0.7×	1.9k 1.6×	1.2k 1.3×	307	11.4k
Richard B. Lock Australia	53	5.1k 1.3×	2.8k 1.0×	1.2k 0.7×	952 0.8×	1.0k 1.1×	260	8.7k
Alan K. Meeker United States	57	5.2k 1.3×	3.6k 1.3×	1.6k 0.9×	2.6k 2.2×	1.5k 1.8×	178	11.1k
Sai‐Ching J. Yeung United States	46	4.7k 1.2×	3.2k 1.1×	2.1k 1.2×	921 0.8×	536 0.6×	237	8.5k
Mitch A. Phelps United States	38	3.0k 0.7×	1.4k 0.5×	967 0.5×	722 0.6×	713 0.8×	199	6.9k
Jacques De Grève Belgium	44	3.1k 0.8×	3.4k 1.2×	1.3k 0.7×	1.8k 1.5×	475 0.5×	264	8.3k
William G. Cance United States	55	4.2k 1.0×	2.9k 1.0×	1.8k 1.0×	940 0.8×	642 0.7×	174	9.2k

Countries citing papers authored by Nicolás André

Since Specialization

Citations

This map shows the geographic impact of Nicolás André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás André more than expected).

Fields of papers citing papers by Nicolás André

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolás André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás André. The network helps show where Nicolás André may publish in the future.

Co-authorship network of co-authors of Nicolás André

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolás André. A scholar is included among the top collaborators of Nicolás André based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolás André. Nicolás André is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Desai, Ami V., Amy E. Armstrong, Cornelis M. van Tilburg, et al.. (2025). Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions. European Journal of Cancer. 220. 115308–115308. 1 indexed citations

Wicinski, Julien, Nicolás André, Lounes Djerroudi, et al.. (2024). A novel bioinformatic approach reveals cooperation between Cancer/Testis genes in basal-like breast tumors. Oncogene. 43(18). 1369–1385. 1 indexed citations

André, Nicolás, Marie‐Cécile Le Deley, Isabelle Aerts, et al.. (2024). METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors. European Journal of Cancer. 198. 113525–113525. 5 indexed citations

Fontugne, Jacqueline, Jennifer Wong, Luc Cabel, et al.. (2023). Progression‐associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis. The Journal of Pathology. 259(4). 455–467. 13 indexed citations

Moreddu, Éric, Nicolás André, & Romain Appay. (2023). Mammary‐analog secretory carcinoma in children: Surgery or TRK inhibitors first?. Pediatric Blood & Cancer. 70(9). e30504–e30504. 2 indexed citations

Doz, François, Nicolás André, Jaume Mora, et al.. (2023). Safety and PK (pharmacokinetic) profile of niraparib (nir) + dostarlimab (dost) in pediatric patients (pts) with recurrent or refractory (RR) solid tumors: SCOOP study.. Journal of Clinical Oncology. 41(16_suppl). 10040–10040. 3 indexed citations

Ninove, Läétitia, et al.. (2023). BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up. Vaccines. 11(5). 989–989. 5 indexed citations

Moreno, Lucas, Pierre Teira, James M. Croop, et al.. (2023). A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors. Frontiers in Pediatrics. 11. 1183295–1183295. 5 indexed citations

Yamasaki, Toshihide, Marie-Pierre Montero, Anne Rodallec, et al.. (2023). Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors. Chemical Science. 14(29). 7988–7998. 2 indexed citations

10.

Timperi, Eleonora, Paul Gueguen, Martina Molgora, et al.. (2022). Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer. Cancer Research. 82(18). 3291–3306. 173 indexed citations breakdown →

11.

Benzekry, Sébastien, et al.. (2021). Development and Validation of a Prediction Model of Overall Survival in High-Risk Neuroblastoma Using Mechanistic Modeling of Metastasis. JCO Clinical Cancer Informatics. 5(5). 81–90. 11 indexed citations

12.

Würthwein, Gudrun, Claudia Lanvers‐Kaminsky, Nicolás André, et al.. (2020). Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure. BMC Pharmacology and Toxicology. 21(1). 37–37. 10 indexed citations

13.

Ciccolini, Joseph, Dominique Barbolosi, Christophe Meille, et al.. (2017). Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy. Cancer Research. 77(17). 4723–4733. 29 indexed citations

14.

Bièche, Ivan, Didier Meseure, Elisabetta Marangoni, et al.. (2016). Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer. Clinical Cancer Research. 23(8). 2116–2126. 26 indexed citations

15.

Meseure, Didier, Sophie Vacher, Kinan Drak Alsibai, et al.. (2016). Expression of ANRIL –Polycomb Complexes– CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene ( EZH2/CBX7 ) Signature with Independent Prognostic Value. Molecular Cancer Research. 14(7). 623–633. 82 indexed citations

16.

Benzekry, Sébastien, Laëtitia Padovani, Christophe Meille, et al.. (2016). Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy. Cancer Research. 76(17). 4931–4940. 122 indexed citations

17.

Nunes, Manoel, Patricia Vrignaud, Sophie Vacher, et al.. (2015). Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data. Cancer Research. 75(8). 1560–1566. 56 indexed citations

18.

André, Nicolás, Shripad Banavali, Yuliya Snihur, & Eddy Pasquier. (2013). Has the time come for metronomics in low-income and middle-income countries?. The Lancet Oncology. 14(6). e239–e248. 111 indexed citations

19.

Hubert, Pascale, Sophie Viel, Nicolás André, et al.. (2011). Antibody-Dependent Cell Cytotoxicity Synapses Form in Mice during Tumor-Specific Antibody Immunotherapy. Cancer Research. 71(15). 5134–5143. 100 indexed citations

20.

Meyniel, Jean-Philippe, Paul Cottu, Charles Decraene, et al.. (2010). A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer. BMC Cancer. 10(1). 222–222. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact